Ophthalmic Company Gets Form 483 on Procedure, Validation Issues
American Optisurgical, an ophthalmic device company based in Lake Forest, Calif., received a 13-observation Form 483 after an inspection by Irvine, Calif., CDRH staff stretching from Jan. 30 to Feb. 23.
The devicemaker lacked procedures defining the responsibility for review, and establishing authority for the disposition of nonconforming products, according to the FDA’s Form 483.
Additionally there were insufficient procedures for receiving, reviewing and for evaluating complaints by a formerly designated unit.
Having a centralized location for your procedures is integral when the FDA pays you a visit.
Next time the FDA comes to your company, who is going to be in your war room and how should you determine assigned roles and seniority? What kinds of information should you provide — and what’s off limits to the FDA?
This detailed webinar goes far above where those other basic “how to prepare for inspections” seminars peak. Too often, companies slap together what is essentially the central nervous system of their inspections. With Creating, Staffing and Managing an Inspection War Room, you will get the who, what, where, why and how behind every good inspection. Register today!
Come for this valuable opportunity to hear FDA officials discuss regulatory plans and objectives — and ask questions you need answered; learn from device industry experts, consultants and other experts with actionable tips and strategies you can take straight back to the office; and network with other professionals who understand your challenges; share war stories and insights over a drink. Register Today.Read More
The FDA's new enforcement plan makes one thing clear: Developing a successful CAPA program has never been more important. But creating an FDA-proof CAPA isn’t easy. If only you could pick the brain of someone who is coping successfully with CAPA — the best and the brightest, an industry leader who has devised programs, procedures and solutions that have put companies out in front with the FDA. Well, you can. Register today.Read More
The FDA’s cadre of freshly trained inspectors — many of whom come directly from industry — and increased focus on specialized inspections are making it harder than ever to predict the outcome of your next FDA inspection. Unless, of course, you have Surviving an FDA Inspection at your fingertips. If you could spend less than $400 to get your drug manufacturing facility fully prepared to face a tough inspection by the FDA, would you even hesitate? ... Of course not!